AB0441 NAILFOLDCAPILLAROSCOPY and Candidate Biomarker Levels in Systemic Sclerosis- Associated Pulmonary Hypertension; Profiling of Non-Invasive Markers, a Cohort Study (original) (raw)

Screening for Pulmonary Hypertension in Systemic Sclerosis—A Primer for Cardio-Rheumatology Clinics

Carina Mihai

Diagnostics, 2021

View PDFchevron_right

An Evidence-Based Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT Study

Madelon Vonk

CHEST Journal, 2012

View PDFchevron_right

Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening

Carlos Cañas

European respiratory review : an official journal of the European Respiratory Society, 2011

View PDFchevron_right

Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up

Rogério Rufino

BMC Pulmonary Medicine, 2021

View PDFchevron_right

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

Loïc Guillevin

Arthritis & Rheumatism, 2011

View PDFchevron_right

Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study

Roberto Badagliacca

Rheumatology, 2013

View PDFchevron_right

Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury

Raphaël Lemaire

2010

View PDFchevron_right

Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort

Carina Mihai

Annals of the rheumatic diseases, 2017

View PDFchevron_right

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study

Vivien Hsu

Seminars in Arthritis and Rheumatism, 2014

View PDFchevron_right

OP0238 Immunosuppression with Targeted Dmards Reduces Morbidity and Mortality in Pre-Capillary Pulmonary Hypertension Associated with Systemic Sclerosis: A Eustar Analysis

Daniela Opris-Belinski

Annals of the Rheumatic Diseases, 2023

View PDFchevron_right

Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Richard Silver

Arthritis Care & Research, 2014

View PDFchevron_right

Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations

Lorenzo Beretta

Arthritis & Rheumatism, 2011

View PDFchevron_right

Pulmonary arterial hypertension associated with systemic sclerosis

Maurice Beghetti, Stephen Mathai

Expert Review of Respiratory Medicine, 2011

View PDFchevron_right

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)

Rahul Argula

Therapeutics and Clinical Risk Management, 2019

View PDFchevron_right

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment

Carlo Gabriele Tocchetti

International Journal of Molecular Sciences

View PDFchevron_right

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis

Christophe Guignabert

Annals of the Rheumatic Diseases, 2022

View PDFchevron_right

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis

Jérôme Le Pavec

PloS one, 2018

View PDFchevron_right

Systemic Sclerosis-associated Pulmonary Arterial Hypertension

Jérôme Le Pavec

American Journal of Respiratory and Critical Care Medicine, 2010

View PDFchevron_right

Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis

J. Seibold

Rheumatology, 2006

View PDFchevron_right

The role of nailfold capillaroscopy in monitoring lung involvement in systemic sclerosis

Violeta Claudia Bojinca

Romanian Journal of Rheumatology

View PDFchevron_right

Diagnosis and management of pulmonary hypertension in systemic sclerosis

Amit Patel, Ray Sawaqed

Current rheumatology reports, 2010

View PDFchevron_right

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study

Molla Huq

BMC pulmonary medicine, 2016

View PDFchevron_right

Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis

Pieter E Postmus

Annals of the Rheumatic Diseases, 2009

View PDFchevron_right

Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

Rosalia Torres

The Journal of Rheumatology, 2010

View PDFchevron_right

Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary Hypertension

Olivier Delezay

View PDFchevron_right

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

J. Seibold

Annals of the Rheumatic Diseases, 2013

View PDFchevron_right

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

Pascal de Groote

Arthritis & Rheumatism, 2009

View PDFchevron_right

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis

Maureen Rischmueller

Arthritis research & therapy, 2015

View PDFchevron_right

Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort

Dilia Giuggioli

2013

View PDFchevron_right

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

Pascal de Groote

Arthritis & Rheumatism, 2005

View PDFchevron_right